POLYMORPHIC FORMS OF (9-[(R)-2-[[(S)-[[(S)-1- (ISOPROPOXYCARBONYL)ETHYL]AMINO]PHENOXY PHOSPHINYL]METHOXY]PROPYL] ADENINE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF

POLYMORPHIC FORMS OF (9-[(R)-2-[[(S)-[[(S)-1- (ISOPROPOXYCARBONYL)ETHYL]AMINO]PHENOXY PHOSPHINYL]METHOXY]PROPYL] ADENINE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF

The present invention discloses novel crystalline polymorphic forms of (9-[(R)-2-[[(S)-[[(S)-1-(isopropoxy carbonyl) ethyl] amino] phenoxyphosphinyl] methoxy]propyl] adenine hemifumarate and 9-[(R)-2-[[(S)-[[(S)-1-(isopropoxycarbonyl)ethyl] amino]phenoxy phosphinyl]methoxy]propyl] adenine monofumara...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: MALHOTRA, Geena, CHENNURU, Ramanaiah, PATHI, Srinivas Laxminarayan, RAO, Dharmaraj Ramachandra, PHULL, Manjinder Singh
Format: Patent
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator MALHOTRA, Geena
CHENNURU, Ramanaiah
PATHI, Srinivas Laxminarayan
RAO, Dharmaraj Ramachandra
PHULL, Manjinder Singh
description The present invention discloses novel crystalline polymorphic forms of (9-[(R)-2-[[(S)-[[(S)-1-(isopropoxy carbonyl) ethyl] amino] phenoxyphosphinyl] methoxy]propyl] adenine hemifumarate and 9-[(R)-2-[[(S)-[[(S)-1-(isopropoxycarbonyl)ethyl] amino]phenoxy phosphinyl]methoxy]propyl] adenine monofumarate, methods of preparation, pharmaceutical compositions and methods of therapeutic treatment involving polymorphic forms thereof.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ZA201900011B</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ZA201900011B</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ZA201900011B3</originalsourceid><addsrcrecordid>eNqNjEFqwzAQRb3poqS9w2RnLwR2uspyrIyRQNIISYUqxoQQlFVIAumZes6qkAN0M5_57828Nj-eTbYcvNISJg42Ak_QbsXchk5sxDy3sXvOQUCrI_vAnr-yxDCyy6ajpLJZ0GrHi1fkKgOvONaXFS-28lotf2d1BdyR044A3a5qGCxK-kxaojEZUEryCUdDENGkCElRIJ7empfz8fIo789cNeuJklSi3G-H8rgfT-Vavg973PTDtu_7YRg__uP8Ap0ZR4s</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>POLYMORPHIC FORMS OF (9-[(R)-2-[[(S)-[[(S)-1- (ISOPROPOXYCARBONYL)ETHYL]AMINO]PHENOXY PHOSPHINYL]METHOXY]PROPYL] ADENINE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF</title><source>esp@cenet</source><creator>MALHOTRA, Geena ; CHENNURU, Ramanaiah ; PATHI, Srinivas Laxminarayan ; RAO, Dharmaraj Ramachandra ; PHULL, Manjinder Singh</creator><creatorcontrib>MALHOTRA, Geena ; CHENNURU, Ramanaiah ; PATHI, Srinivas Laxminarayan ; RAO, Dharmaraj Ramachandra ; PHULL, Manjinder Singh</creatorcontrib><description>The present invention discloses novel crystalline polymorphic forms of (9-[(R)-2-[[(S)-[[(S)-1-(isopropoxy carbonyl) ethyl] amino] phenoxyphosphinyl] methoxy]propyl] adenine hemifumarate and 9-[(R)-2-[[(S)-[[(S)-1-(isopropoxycarbonyl)ethyl] amino]phenoxy phosphinyl]methoxy]propyl] adenine monofumarate, methods of preparation, pharmaceutical compositions and methods of therapeutic treatment involving polymorphic forms thereof.</description><language>eng</language><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220330&amp;DB=EPODOC&amp;CC=ZA&amp;NR=201900011B$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76294</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220330&amp;DB=EPODOC&amp;CC=ZA&amp;NR=201900011B$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MALHOTRA, Geena</creatorcontrib><creatorcontrib>CHENNURU, Ramanaiah</creatorcontrib><creatorcontrib>PATHI, Srinivas Laxminarayan</creatorcontrib><creatorcontrib>RAO, Dharmaraj Ramachandra</creatorcontrib><creatorcontrib>PHULL, Manjinder Singh</creatorcontrib><title>POLYMORPHIC FORMS OF (9-[(R)-2-[[(S)-[[(S)-1- (ISOPROPOXYCARBONYL)ETHYL]AMINO]PHENOXY PHOSPHINYL]METHOXY]PROPYL] ADENINE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF</title><description>The present invention discloses novel crystalline polymorphic forms of (9-[(R)-2-[[(S)-[[(S)-1-(isopropoxy carbonyl) ethyl] amino] phenoxyphosphinyl] methoxy]propyl] adenine hemifumarate and 9-[(R)-2-[[(S)-[[(S)-1-(isopropoxycarbonyl)ethyl] amino]phenoxy phosphinyl]methoxy]propyl] adenine monofumarate, methods of preparation, pharmaceutical compositions and methods of therapeutic treatment involving polymorphic forms thereof.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjEFqwzAQRb3poqS9w2RnLwR2uspyrIyRQNIISYUqxoQQlFVIAumZes6qkAN0M5_57828Nj-eTbYcvNISJg42Ak_QbsXchk5sxDy3sXvOQUCrI_vAnr-yxDCyy6ajpLJZ0GrHi1fkKgOvONaXFS-28lotf2d1BdyR044A3a5qGCxK-kxaojEZUEryCUdDENGkCElRIJ7empfz8fIo789cNeuJklSi3G-H8rgfT-Vavg973PTDtu_7YRg__uP8Ap0ZR4s</recordid><startdate>20220330</startdate><enddate>20220330</enddate><creator>MALHOTRA, Geena</creator><creator>CHENNURU, Ramanaiah</creator><creator>PATHI, Srinivas Laxminarayan</creator><creator>RAO, Dharmaraj Ramachandra</creator><creator>PHULL, Manjinder Singh</creator><scope>EVB</scope></search><sort><creationdate>20220330</creationdate><title>POLYMORPHIC FORMS OF (9-[(R)-2-[[(S)-[[(S)-1- (ISOPROPOXYCARBONYL)ETHYL]AMINO]PHENOXY PHOSPHINYL]METHOXY]PROPYL] ADENINE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF</title><author>MALHOTRA, Geena ; CHENNURU, Ramanaiah ; PATHI, Srinivas Laxminarayan ; RAO, Dharmaraj Ramachandra ; PHULL, Manjinder Singh</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ZA201900011B3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>online_resources</toplevel><creatorcontrib>MALHOTRA, Geena</creatorcontrib><creatorcontrib>CHENNURU, Ramanaiah</creatorcontrib><creatorcontrib>PATHI, Srinivas Laxminarayan</creatorcontrib><creatorcontrib>RAO, Dharmaraj Ramachandra</creatorcontrib><creatorcontrib>PHULL, Manjinder Singh</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MALHOTRA, Geena</au><au>CHENNURU, Ramanaiah</au><au>PATHI, Srinivas Laxminarayan</au><au>RAO, Dharmaraj Ramachandra</au><au>PHULL, Manjinder Singh</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>POLYMORPHIC FORMS OF (9-[(R)-2-[[(S)-[[(S)-1- (ISOPROPOXYCARBONYL)ETHYL]AMINO]PHENOXY PHOSPHINYL]METHOXY]PROPYL] ADENINE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF</title><date>2022-03-30</date><risdate>2022</risdate><abstract>The present invention discloses novel crystalline polymorphic forms of (9-[(R)-2-[[(S)-[[(S)-1-(isopropoxy carbonyl) ethyl] amino] phenoxyphosphinyl] methoxy]propyl] adenine hemifumarate and 9-[(R)-2-[[(S)-[[(S)-1-(isopropoxycarbonyl)ethyl] amino]phenoxy phosphinyl]methoxy]propyl] adenine monofumarate, methods of preparation, pharmaceutical compositions and methods of therapeutic treatment involving polymorphic forms thereof.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_ZA201900011B
source esp@cenet
title POLYMORPHIC FORMS OF (9-[(R)-2-[[(S)-[[(S)-1- (ISOPROPOXYCARBONYL)ETHYL]AMINO]PHENOXY PHOSPHINYL]METHOXY]PROPYL] ADENINE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T23%3A41%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MALHOTRA,%20Geena&rft.date=2022-03-30&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EZA201900011B%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true